A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 99
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MODS
Long Form : microscopic observation drug susceptibility
No. Year Title Co-occurring Abbreviation
2021 Evaluation of tuberculosis diagnostic tools, with extending MODS assay use to second line susceptibility testing. DST
2020 Direct Determination of Pyrazinamide (PZA) Susceptibility by Sputum Microscopic Observation Drug Susceptibility (MODS) Culture at Neutral pH: the MODS-PZA Assay. DST, PZA
2020 Microscopic Observation Drug Susceptibility (MODS) Assay: A Convenient Method for Determining Antibiogram of Clinical Isolates of Mycobacterium tuberculosis in Ghana. DST, Mtb, SIRE
2019 Evaluation of Microscopic observation drug susceptibility (MODS) assay as a rapid, sensitive and inexpensive test for detection of tuberculosis and multidrug resistant tuberculosis. DST, LJ, MDR-TB, MGIT, TB
2019 Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review. CRI, DST, EMB, MDR-TB, TB, TLA
2019 Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance. DSTs, MGIT, NRA, REMA, RR
2018 Assessments of Different Methods for Testing Heteroresistance to Rifampicin in Tubercle Bacillus. HRM, L-J, RIF, RT-PCR, TB
2018 Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis. TB
2018 Microbiological diagnosis of adult tuberculous meningitis in a ten-year cohort in Indonesia. CSF, TB
10  2018 MODS-Wayne, a Colorimetric Adaptation of the Microscopic-Observation Drug Susceptibility (MODS) Assay for Detection of Mycobacterium tuberculosis Pyrazinamide Resistance from Sputum Samples. MDR-TB, PZA, XDR-TB
11  2018 pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects. PZA
12  2018 Progress on Diagnosis of Tuberculous Meningitis. CNS, IGRAs, LCSS, Mtb, TB, TBM, ZN
13  2018 Rapid drug susceptibility testing and treatment outcomes for multidrug-resistant tuberculosis in Peru. DST, MDR-TB
14  2017 A suggested algorithm for detection of multi drug-resistant tuberculosis in Zimbabwe. DST, LJ, MDR-TB, MGIT, TAT
15  2017 Bacteriological diagnosis of childhood TB: a prospective observational study. ---
16  2017 Concurrent evaluation of microscopic observation of drug susceptibility assay for pulmonary and extrapulmonary tuberculosis. DST, LJ, MDR-TB, MTB, RIF, TB
17  2017 Microscopic observation drug-susceptibility assay vs. Xpert MTB/RIF for the diagnosis of tuberculosis in a rural African setting: a cost-utility analysis. DALY, ICER, SM, TB, WPT
18  2017 Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali. MDR-TB
19  2017 The value of microscopic-observation drug susceptibility assay in the diagnosis of tuberculosis and detection of multidrug resistance. LJ, MTBC
20  2016 Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda. PTB
21  2016 Cost-effectiveness of Diagnostic Algorithms for Tuberculosis in Children Less Than 5 Years of Age. TB, YLG
22  2016 Evaluation of a lens-free imager to facilitate tuberculosis diagnostics in MODS. MDR, Mtb, TB, XDR
23  2016 Feasibility and cost analysis of programmatic implementation of Microscopic-Observation Drug Susceptibility (MODS) assay in Nigeria. MDR-TB
24  2015 A Controlled Study of Tuberculosis Diagnosis in HIV-Infected and Uninfected Children in Peru. ---
25  2015 Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia. LJ, MDR-TB, Mtb, TB, ZN
26  2015 Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance. DST, TB
27  2015 Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis. AMK, CAP, KAN, LPA, MOX, OFX, PSQ, RIF
28  2015 The indirect microscopic observation drug susceptibility assay demonstrated high concordance with the indirect MGIT method for pyrazinamide susceptibility testing. MGIT
29  2014 Car windshield fragments as cheap alternative glass beads for homogenization of Mycobacterium tuberculosis cultures in a resource-limited setting. ---
30  2014 Evaluating the Auto-MODS assay, a novel tool for tuberculosis diagnosis for use in resource-limited settings. Auto-MODS, CI, MDR, MGIT, TB
31  2014 Evaluation of indirect drug susceptibility testing using the MODS assay for the detection of XDR-TB in China. KM, MDR, OFX, RMP, XDR-TB
32  2014 Evaluation of MODS assay for rapid detection of Mycobacterium tuberculosis resistance to second-line drugs in a tertiary care tuberculosis hospital in China. ---
33  2014 Evaluation of p-nitro benzoic acid (pnb) inhibition test to differentiate Mycobacterium tuberculosis complex from non-tuberculous mycobacteria using microscopic observation of drug susceptibility (MODS) methodology. Mtb, NTM, PNB
34  2014 Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study. DST, MGIT
35  2014 Microscopic observation drug susceptibility (MODS): where are we going? ---
36  2014 Microscopic observation drug susceptibility assay for the diagnosis of TB and MDR-TB in HIV-infected patients: a systematic review and meta-analysis. MDR, TB
37  2014 Optimization of the microscopic observation drug susceptibility assay for four first-line drugs using Mycobacterium tuberculosis reference strains and clinical isolates. DST, EMB, LJ, RMP, STR, TB
38  2014 Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. AMK, CPM, DST, KM, MFX, OFX
39  2014 [Implementation of a telediagnostic system for tuberculosis and determination of multi-drug resistance based in the MODS method in Trujillo, Peru]. MDR
40  2013 A rapid and low-cost microscopic observation drug susceptibility assay for detecting TB and MDR-TB among individuals infected by HIV in South India. MDR-TB, TB
41  2013 Diagnostic accuracy of microscopic Observation Drug Susceptibility (MODS) assay for pediatric tuberculosis in Hanoi, Vietnam. LJ, TB
42  2013 Evaluation of the performance of the microscopic observation drug susceptibility assay for diagnosis of extrapulmonary tuberculosis in China: A preliminary study. LJ, TB, ZN
43  2013 Evaluation of the Xpert MTB/Rif test, microscopic observation drug susceptibility test and nitrate reductase assay, for rapid and accurate diagnosis of smear-negative tuberculosis in HIV patients. MGIT, Mtb, NRA, TB, TM, WHO
44  2013 Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis. TB
45  2013 Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis. SN-PTB
46  2013 Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe. DST, LJ
47  2013 Morphological characterization of Mycobacterium tuberculosis in a MODS culture for an automatic diagnostics through pattern recognition. Mtb
48  2013 Performance of the microscopic observation drug susceptibility assay in pyrazinamide susceptibility testing for Mycobacterium tuberculosis. LJ, M. tuberculosis
49  2013 Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 1: Microscopic Observation Drug Susceptibility Assay v2.4.12. DST
50  2013 Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment. DST, LJ, TB
51  2012 Effect of universal MODS access on pulmonary tuberculosis treatment outcomes in new patients in Peru. DST, MDR-TB, TB
52  2012 Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam. DST, DST-MODS, LJ, MAS-PCR, MDR-TB, MOTT, RIF, TB
53  2012 Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis. DST, LJ, MDR-TB, TB
54  2012 Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis. MDR-TB, RMP
55  2012 Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB. AST, DST, HIV, MDR-TB, TB
56  2012 Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay. DST, TB
57  2012 Training laboratory technicians from the Ethiopian periphery in the MODS technique enables rapid and low-cost diagnosis of Mycobacterium tuberculosis infection. TB
58  2011 Development of an automated MODS plate reader to detect early growth of Mycobacterium tuberculosis. ---
59  2011 Diagnosis of tuberculosis: the experience at a specialized diagnostic laboratory. ---
60  2011 Direct nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in Uganda. DR, LJ, NRA, RLSs
61  2011 Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis. NRA, PM, REMA, TB
62  2011 Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide. ACM, BMM, PZase
63  2011 Microcolony culture techniques for tuberculosis diagnosis: a systematic review. TB, TLA
64  2011 Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay. CI, DST, IQR, MDR, TB
65  2011 Reliability of the MODS assay decentralisation process in three health regions in Peru. DST, INS, MDR-TB, RMP
66  2011 [Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of mycobacterium tuberculosis in smear-positive sputum]. ---
67  2010 Development of low-cost inverted microscope to detect early growth of Mycobacterium tuberculosis in MODS culture. ---
68  2010 Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay. MGIT, TB
69  2010 Diagnostic accuracy of the microscopic observation drug susceptibility assay: a pilot study from India. TB
70  2010 Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. ---
71  2010 Evaluation of seven tests for the rapid detection of multidrug-resistant tuberculosis in Uganda. DST, NRA, RMP, TB
72  2010 Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. HIV, IPT, TB
73  2010 Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. TLA
74  2010 MODS accreditation process for regional reference laboratories in Peru: validation by GenoType MTBDRplus. DST, MDR-TB, RMP, TB, UPCH
75  2010 Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. DOTS, DSTs
76  2010 Rapid diagnosis of tuberculosis and multidrug resistance with the microscopic observation drug susceptibility assay in Ecuador. ---
77  2010 Simplified automated image analysis for detection and phenotyping of Mycobacterium tuberculosis on porous supports by monitoring growing microcolonies. NA, PAO
78  2010 Utility of Microscopic Observation of Drug Susceptibility (MODS) assay for Mycobacterium tuberculosis in resource constrained settings. DST, LJ, MDR-TB, Mtb
79  2009 Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. MDR-TB, NRA, SROC, TB
80  2009 Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance. MGIT, NRA, PM
81  2009 Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. TB
82  2009 [Detection on drug resistance of Mycobacterium tuberculosis by microscopic observation drug susceptibility]. LJ, MIC, Mtb
83  2008 Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries? TB
84  2008 Improved diagnosis of pleural tuberculosis using the microscopic- observation drug-susceptibility technique. ---
85  2008 Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. DST, MDR-TB
86  2008 Physician-initiated courtesy MODS testing for TB and MDR-TB diagnosis and patient management. DST, UPCH
87  2008 Reducing the string test intra-gastric downtime for detection of Mycobacterium tuberculosis. IGDT, TB
88  2008 The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis. MDR-TB, Mtb, TB
89  2007 Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. ---
90  2007 Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. CI, IQR, MGIT
91  2007 Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. MDR-TB
92  2007 Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis. CSF, LJ, MGIT, TBM, ZN
93  2007 Solar disinfection of MODS mycobacterial cultures in resource-poor settings. CFU
94  2006 Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis. BMM, NRA, PM
95  2006 Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting. LJ
96  2006 Microscopic-observation drug-susceptibility assay for the diagnosis of TB. ---
97  2004 Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. LJ, MABA, MDR-TB, TB, TEMA
98  2002 Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. ---
99  2000 Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. MABA, Mtb